4,880
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Preparation, characterization, and pharmacodynamics of insulin-loaded fumaryl diketopiperazine microparticle dry powder inhalation

, , , , , , & show all
Pages 650-660 | Received 04 May 2019, Accepted 09 Jun 2019, Published online: 01 Jul 2019

References

  • Andrade F, Das NJ, Gener P, et al. (2015). Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin. Nanomed Nanotechnol Biol Med 11:1621–31.
  • Angelo R, Rousseau K, Grant M, et al. (2009). Technosphere(R) insulin: defining the role of technosphere particles at the cellular level. J Diabetes Sci Technol 3:545–54.
  • Becker RH, Frick AD. (2008). Clinical pharmacokinetics and pharmacodynamics of insulin glulisine. Clin Pharmacokinet 47:7–20.
  • Cai L, Zhu Z. (2007). Progress in non-invasive routes for insulin preparations. J China Pharm Univ 38:105–7.
  • Cassidy JP, Amin N, Marino M, et al. (2011). Insulin lung deposition and clearance following Technosphere® insulin inhalation powder administration. Pharm Res 28:2157–64.
  • Chan HK. (2006). Dry powder aerosol delivery systems: current and future research directions. J Aerosol Med 19:21–7.
  • Chvatal A, Ambrus R, Party P, et al. (2019). Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery. Int J Pharm 559:68–75.
  • Courrier HM, Butz N, Vandamme TF. (2002). Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug Carrier Syst 19:425.
  • Cuvelier B, Eloy P, Loira C, et al. (2015). Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation. Int J Pharm 495:981–90.
  • Fantasia HC. (2015). Inhaled insulin – a new delivery for an old drug. Nurs Womens Health 19:67–70.
  • Flament MP, Leterme P, Gayot A. (2004). The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers. Int J Pharm 275:201–9.
  • Frid AH, Hirsch LJ, Menchior AR, et al. (2016). Worldwide injection technique questionnaire study: injecting complications and the role of the professional. Mayo Clin Proc 91:1224–30.
  • Harsch IA. (2005). Inhaled insulins: their potential in the treatment of diabetes mellitus. Treat Endocrinol 4:131–8.
  • Healy AM, Amaro MI, Paluch KJ, et al. (2014). Dry powders for oral inhalation free of lactose carrier particles. Adv Drug Deliv Rev 75:32–52.
  • Hickey A. Pharmaceutical inhalation aerosol technology. 2nd ed. Boca Raton, FL: CRC Press. 2003.
  • Hovelmann U, Heise T, Nosek L, et al. (2017). Pharmacokinetic properties of fast-acting insulin aspart administered in different subcutaneous injection regions. Clin Drug Investig 37:503–9.
  • Ishii H, Niiya T, Ono Y, et al. (2017). Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study. Diabetol Metab Syndr 9:3.
  • Jiang Z, Shi D, Tu Y, et al. (2018). Human proislet peptide promotes pancreatic progenitor cells to ameliorate diabetes via FOXO1/menin-mediated epigenetic regulation. Diabetes 67:1345–55.
  • Liang HR, Tang HW, Luo H, Hu DL. (2006). Evaluation of experimental rat model of diabetic nephropathy induced by streptozotocin (STZ). Appl Prev Med 12:133–5.
  • Liu XB, Ye JX, Quan LH, et al. (2008). Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats. Eur J Pharm Biopharm 70:845–52.
  • Maker AV, Sheikh R, Bhagia V. (2017). Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia. Langenbecks Arch Surg 402:873–83.
  • Nagai Y, Ohshige T, Arai K, et al. (2013). Comparison between shorter straight and thinner microtapered insulin injection needles. Diabetes Technol Ther 15:550–5.
  • Olivera EM, Elbert A, Lercari JM, et al. (1996). [Current situation of diabetic patients in hemodialysis in Buenos Aires]. Medicina (Buenos Aires) 56:657–65.
  • Pilcer G, Amighi K. (2010). Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm 392:1–19.
  • Pilcer G, Wauthoz N, Amighi K. (2012). Lactose characteristics and the generation of the aerosol. Adv Drug Deliv Rev 64:233–56.
  • Potocka E, Cassidy JP, Haworth P, et al. (2010). Pharmacokinetic characterization of the novel pulmonary delivery excipient fumaryl diketopiperazine. J Diabetes Sci Technol 4:1164–73.
  • Qian H, Rui-Ming LU. (2015). Current situation and progress of study on diabetes. Med Recapitulate 21:1.
  • Rendell M. (2014). Technosphere Inhaled Insulin (Afrezza). Drugs Today 50:813–28.
  • Savill JS, Wyllie AH, Henson JE, et al. (1989). Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83:865–75.
  • Shi J, Lin W, Liao H. (2012). Optimization of preparation technology for Gefen instant granule by Z-comprehensive scoring method. Chin J Exp Tradition Med Formulae 18:56–9.
  • Stegemann S, Kopp S, Borchard G, et al. (2013). Developing and advancing dry powder inhalation towards enhanced therapeutics. Eur J Pharm Sci 48:181–94.
  • Vartiainen V, Bimbo LM, Hirvonen J, et al. (2016). Drug permeation and cellular interaction of amino acid-coated drug combination powders for pulmonary delivery. Int J Pharm 504:89–97.
  • Wang Q, Mi G, Hickey D, et al. (2018). Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia. Biomaterials 160:107–23.
  • Wang ZW, Lei H. (2011). Clinical research on aerosolizing insulin inhalation in the treatment of smear positive pulmonary tuberculosis with diabetes. Med J Chin People’s Health 23:3–4.
  • Wenzel P, Daiber A, Oelze M, et al. (2008). Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 198:65–76.
  • Wong TW. (2009). Chitosan and its use in design of insulin delivery system. Recent Pat Drug Deliv Formul 3:8–25.
  • Xue W, Liu X, Yu W, et al. (2006). Preparation of protein-loaded microspheres with size < =10 μm by electrostatic droplet generation technology. Chin Sci Bull 51:279–86.
  • Zeng XM, Pandhal KH, Martin GP. (2000). The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols. Int J Pharm 197:41–52.
  • Zhang L, Bi R, Zhang N. (2008). Studies on the non-invasive ways of delivery of protein polypeptides. Chin J Pharm Anal 28:333–6.